Task: Answer Verification
Input (English): Question: Are serum levels of the advanced glycation end products Nepsilon-carboxymethyllysine and pentosidine influenced by treatment with the angiotensin receptor II type 1 blocker irbesartan in patients with type 2 diabetic nephropathy and hypertension?
Answer: Irbesartan did not alter the increase in pentosidine and CML in serum of type 2 diabetic patients with progressive nephropathy. This finding suggests that angiotensin receptor blockade alone is insufficient to reduce serum levels of AGEs in diabetic nephropathy.
Output (English): no